Tempest Therapeutics Names Stephanie Horn-Warnock CFO

• Tempest Therapeutics appointed Stephanie Horn-Warnock chief financial officer effective immediately on October 26, 2026.
• She succeeds Constance Ames, who resigned immediately that day for personal reasons unrelated to the company.
• Horn-Warnock also became principal financial and accounting officer, treasurer and corporate secretary.
• She served as ROM Technologies’ vice president of finance from January 2024 to September 2026, overseeing accounting and finance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-114376), on October 30, 2026, and is solely responsible for the information contained therein.